HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors

Author： Fuerst Daniel   Parmar Sumit   Schumann Christian   Rüdiger Stefan   Boeck Stefan   Heinemann Volker   Kaechele Volker   Stiebel Kristina   Paul Tanusree   Seufferlein Thomas   Mytilineos Joannis   Stingl Julia Carolin  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.13, 2012-10, pp. : 1469-1476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Development of PDGF Receptor Inhibitors for the Treatment of Glioma: A Review

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 4, 2010-05 ,pp. : 290-299

Bentham Science Publishers

Access to resources Recommend Favorite

Compounds and methods for the treatment of EGF receptor associated cancers and purification of the EGF receptor

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 8, 1997-08 ,pp. : 895-897

Informa Healthcare

Access to resources Recommend Favorite

Skin reactions related to treatment with anticytokines, membrane receptor inhibitors and monoclonal antibodies

By Dereure O  

Expert Opinion on Drug Safety, Vol. 2, Iss. 5, 2003-09 ,pp. : 467-473

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers

By KHAN MISBAH H.   ALAM MURAD   YOO SIMON  

Dermatologic Surgery, Vol. 37, Iss. 9, 2011-09 ,pp. : 1199-1209

Elsevier

Access to resources Recommend Favorite

Sorafenib: Skin rash: case report

By  

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 35-35

Adis International

Access to resources Recommend Favorite